NEWLINK GENETICS CORPORATION

Basic Information

NEWLINK GENETICS CORPORATION
2901 S LOOP DR, BLDG 3, STE 3900
AMES, IA, 50010

Company Profile

n/a

Additional Details

Field Value
DUNS: 10664329
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Novel immune-based therapy for leishmaniasis and tuberculosis

    Amount: $363,483.00

    DESCRIPTION (provided by applicant): Indolamine 2,3-deoxygenase enzymes (IDO-1 and IDO-2) play important counter-regulatory roles in the immune system. IDO-mediated tryptophan catabolism induces T cel ...

    STTR Phase I 2009 Department of Health and Human Services
  2. Improved influenza A virus vaccines using alpha-Gal epitope modification

    Amount: $578,784.00

    DESCRIPTION (provided by applicant): Humans develop natural antibodies against a sugar molecule called Gal, which is present on proteins and lipids in most other species. These antibodies represent on ...

    SBIR Phase I 2008 Department of Health and Human Services
  3. VmatchNL- a user-friendly graphical interface for large-scale genome analysis

    Amount: $99,722.00

    DESCRIPTION (provided by applicant): The availability of a reference human genome sequence provides the foundation for studying the genetic and molecular basis of human health and disease. Using a var ...

    SBIR Phase I 2006 Department of Health and Human Services
  4. Exon Boundary Tags (EBTs) for Human Functional Genome Annotation

    Amount: $98,414.00

    DESCRIPTION (provided by applicant): The Human Genome Project has brought the field of functional genomics to the forefront of biological and pharmaceutical research. However, deciphering the function ...

    SBIR Phase I 2006 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government